Overall rank by patents
#36,102
Across all tracked assignees
USPTO PatentsView assignee record - 7 granted patents across 6 technology areas, active 2022–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61H (PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFI).
The verdict
KOYA holds 7 US patents across 6 technology areas, rank #36,102 of 50,000 tracked assignees.
KOYA Medical, Inc. has been granted 7 US utility patents between 2022 and 2025, placing KOYA Medical, Inc. at rank #36,102 across all assignees tracked by PlainPatent. This portfolio spans 6 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.6 claims per patent with primary concentration in A61H (PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFI). As a US Corporation, KOYA Medical, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, KOYA sits between Konica Minolta Planetarium Co., Ltd. (7 patents, rank #36,098) and KT Projektentwicklungs Gmbh (7 patents, rank #36,106) - the closest US assignees by grant volume. The composite Innovation Score of 47.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2022 through 2025, with 7 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. KOYA Medical, Inc.'s 19.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 6 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark KOYA Medical, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
KONICA MINOLTA PLANETARIUM CO., LTD.
7 patents
KORE Wireless Group, Inc.
7 patents
KOREA ASTRONOMY AND SPACE SCIENCE INSTITUTE
7 patents
KOREA JCC CO., LTD.
7 patents
KPS CO., LTD.
7 patents
KRAUSSMAFFEI BERSTORFF GMBH
7 patents
KROHNE S.A.S.
7 patents
KT Projektentwicklungs GmbH
7 patents
KOYA MEDICAL, INC.
7 patents
What this shows KOYA holds 7 patents at rank #36,102, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #36,102 in granted patent volume.
Other assignees with the most granted patents in KOYA's primary technology class.
KOYA's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
48 Top 18% higher than 82% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2022 | 1 | 14.3% |
| 2023 | 3 | 42.9% |
| 2024 | 2 | 28.6% |
| 2025 | 1 | 14.3% |
Top 6 of 6 technology areas
Overall rank by patents
#36,102
Across all tracked assignees
47.6 out of 100
How to use this portfolio
KOYA's 7 grants land it in the top 18% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.